Compare CRUS & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRUS | MMED |
|---|---|---|
| Founded | 1984 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.5B |
| IPO Year | 1997 | 2025 |
| Metric | CRUS | MMED |
|---|---|---|
| Price | $117.88 | $20.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $157.00 | $22.56 |
| AVG Volume (30 Days) | 760.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.83 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | $1,997,379,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $7.12 | $15.99 |
| Revenue Next Year | $0.49 | $10.00 |
| P/E Ratio | $79.51 | ★ N/A |
| Revenue Growth | 5.34 | ★ 14.25 |
| 52 Week Low | $111.00 | $10.65 |
| 52 Week High | $180.42 | $20.88 |
| Indicator | CRUS | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 29.69 | 63.78 |
| Support Level | $116.90 | $10.68 |
| Resistance Level | $127.01 | N/A |
| Average True Range (ATR) | 4.81 | 0.84 |
| MACD | -0.10 | -0.06 |
| Stochastic Oscillator | 13.17 | 68.17 |
Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.